|Bid||9.92 x 1100|
|Ask||10.03 x 3000|
|Day's Range||9.97 - 9.97|
|52 Week Range||9.76 - 10.65|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If you want to know who really controls SCP & CO Healthcare Acquisition Company ( NASDAQ:SHAC ), then you'll have to...
SCP & CO Healthcare Acquisition Company (NASDAQ: SHACU) (the "Company") announced that, commencing March 15, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade shares of the Company's Class A common stock and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols "SHAC" and "SHACW," respectively. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol "SHACU." Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of Class A common stock and warrants.
SCP & CO Healthcare Acquisition Company (the "Company") (NASDAQ: SHACU), announced the closing of its upsized initial public offering of 23,000,000 units at $10.00 per unit, including 3,000,000 units pursuant to the full exercise of the underwriters' over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000.